Position in ARVN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$342,895
-$94,492 QoQ
Shares Held
41,263
0.0% QoQ
Ownership
0.063%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#94
of 201 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARVN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Quinn Opportunity Partners LLC holds $47,802,755 across 24 Biotechnology names. ARVN ranks #18 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BNTX |
BioNTech SE
|
153,832 | $14,314,067 | |
| 2 | NKTR |
Nektar Therapeutics
|
153,076 | $10,686,235 | |
| 3 | ABVX |
Abivax S.A.
|
66,045 | $8,801,156 | |
| 4 | MRVI |
Maravai Lifesciences Holdings, Inc.
|
265,070 | $1,654,036 | |
| 5 | XNCR |
Xencor Inc
|
90,000 | $1,449,000 | |
| 6 | SPRB |
Spruce Biosciences, Inc.
|
26,810 | $1,447,740 | |
| 7 | SPRY |
ARS Pharmaceuticals, Inc.
|
175,000 | $1,401,750 | |
| 8 | ABUS |
Arbutus Biopharma Corp
|
255,214 | $1,225,027 |
All Filings in ARVN
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $342,895 | 41,263 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $437,387 | 41,263 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $489,379 | 41,263 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $521,960 | 61,263 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $524,495 | 71,263 | Shares | Sole | 2025-08-08 | |
| No filing history on record for this holder in this stock. | ||||||